Serum testosterone levels of HbSS (sickle cell disease) male subjects in Lagos, Nigeria
2011

Testosterone Levels in Sickle Cell Disease Males

Sample size: 75 publication Evidence: high

Author Information

Author(s): Abudu Emmanuel K, Akanmu Sulaiman A, Soriyan Oyetunji O, Akinbami Akinsegun A, Adediran Adewumi, Adeyemo Titilope A, Okany Charles C

Primary Institution: Lagos University Teaching Hospital

Hypothesis

What are the serum testosterone levels in male patients with sickle cell disease compared to healthy controls?

Conclusion

Male patients with sickle cell disease have significantly lower serum testosterone levels than healthy controls.

Supporting Evidence

  • 93.6% of HbSS subjects had testosterone levels below the normal range.
  • The mean testosterone level for HbSS patients was significantly lower than that of HbAA controls.
  • Most HbSS subjects experienced delayed onset of puberty.

Takeaway

Boys with sickle cell disease often have lower testosterone, which can affect their growth and ability to have children.

Methodology

An unmatched case-control study with 75 subjects, including 47 HbSS patients and 28 HbAA controls, measuring serum testosterone levels.

Potential Biases

Possible bias due to reliance on participant history regarding drug use and health conditions.

Limitations

Reliance on self-reported data and potential inaccuracies in testosterone measurements.

Participant Demographics

Participants aged 15-45 years, with 47 male patients having homozygous sickle cell disease and 28 healthy male controls.

Statistical Information

P-Value

2.8 × 10-7

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-0500-4-298

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication